Detection of apolipoprotein E/dimeric soluble amyloid beta complexes in Alzheimer's disease brain supernatants.
about
Cerebrospinal Fluid Particles in Alzheimer Disease and Parkinson DiseasePreferential interactions between ApoE-containing lipoproteins and Aβ revealed by a detection method that combines size exclusion chromatography with non-reducing gel-shiftPreventing beta-amyloid fibrillization and deposition: beta-sheet breakers and pathological chaperone inhibitors.Opposite roles of apolipoprotein E in normal brains and in Alzheimer's disease.Apolipoprotein E: a major piece in the Alzheimer's disease puzzle.Amyloid and lipids in the pathology of Alzheimer disease.Influence of lipoproteins on microglial degradation of Alzheimer's amyloid beta-protein.Physicochemical characteristics of soluble oligomeric Abeta and their pathologic role in Alzheimer's disease.Effects of apoE deficiency and occlusal disharmony on amyloid-beta production and spatial memory in ratsApolipoprotein E isoform-dependent amyloid deposition and neuritic degeneration in a mouse model of Alzheimer's diseaseMultiple SNPs within and surrounding the apolipoprotein E gene influence cerebrospinal fluid apolipoprotein E protein levels.AD synapses contain abundant Aβ monomer and multiple soluble oligomers, including a 56-kDa assemblyAmyloid mediates the association of apolipoprotein E e4 allele to cognitive function in older peopleAppearance of sodium dodecyl sulfate-stable amyloid beta-protein (Abeta) dimer in the cortex during aging.Mechanism of cerebral beta-amyloid angiopathy: murine and cellular models.Therapeutic approaches for prion and Alzheimer's diseases.Apolipoprotein E and cholesterol in aging and disease in the brainOxidative stress and cell membranes in the pathogenesis of Alzheimer's disease.Apolipoproteins and amyloid fibril formation in atherosclerosis.Reactivity of apolipoprotein E4 and amyloid beta peptide: lysosomal stability and neurodegeneration.Blocking the apolipoprotein E/amyloid β interaction in triple transgenic mice ameliorates Alzheimer's disease related amyloid β and tau pathology.Human apolipoprotein E4 accelerates beta-amyloid deposition in APPsw transgenic mouse brain.
P2860
Q27314618-1E557B10-1A28-447A-81C9-12E21563641CQ28582464-4F85B23C-E496-45E3-81E0-A85FDEC4DA67Q30855109-3F5B3624-F546-449F-BA52-FE24636BC111Q31949934-0CA1392B-2D0E-4BC6-86E3-111AB3108AF3Q33337322-51A97A9D-53D5-4786-A266-EE01E32451FFQ33706311-F859BDCA-F0E8-463A-8801-E42806D16F28Q33998693-28630471-1305-4402-A60B-7CE8C5B8990CQ34476355-F3A4762D-21F1-4527-9BC8-34C176358E33Q34997429-CCD603E5-5729-467D-A628-27ED34F5481EQ35084110-EB2FB956-2228-4E7F-8199-388500D260E9Q35337926-23337C7C-B235-4A82-83A8-E0C8B469D213Q35353667-5F7F6CFF-5DD5-4018-9BCE-0EDED4F2E895Q35490069-916EF39F-0810-45C7-9EC9-3E2617FE23A9Q35754595-22565046-A752-4B20-B3ED-B2D1F8AB2D61Q36448521-CB55B1FA-9AFE-4BD1-B6C8-8321C05FE377Q36872884-09C375D4-BCA2-44A6-9D78-035FCC728FBCQ37009967-C34F8CBA-73DB-4998-9674-A7F4A51542E3Q37847817-0C68C989-3E0F-402D-AC86-93B091D6A4E9Q37852612-6454F8B3-0333-40AF-A46C-AC503770D24DQ40349274-C3A101CE-A046-45BC-92EF-9AE2D8496E49Q42008541-82E9EB7E-8ABA-465A-AB38-1D7040DD9E18Q48744526-631EB23D-6C37-46C6-838F-D03A3ECD3E51
P2860
Detection of apolipoprotein E/dimeric soluble amyloid beta complexes in Alzheimer's disease brain supernatants.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Detection of apolipoprotein E/ ...... 's disease brain supernatants.
@en
Detection of apolipoprotein E/ ...... 's disease brain supernatants.
@nl
type
label
Detection of apolipoprotein E/ ...... 's disease brain supernatants.
@en
Detection of apolipoprotein E/ ...... 's disease brain supernatants.
@nl
prefLabel
Detection of apolipoprotein E/ ...... 's disease brain supernatants.
@en
Detection of apolipoprotein E/ ...... 's disease brain supernatants.
@nl
P2093
P356
P1476
Detection of apolipoprotein E/ ...... 's disease brain supernatants.
@en
P2093
P304
P356
10.1006/BBRC.1997.7727
P407
P577
1997-11-01T00:00:00Z